Global Biopharmaceutical and Vaccines Market Size, Status and Forecast 2020-2026
- Report Code : SMA1887376
- Published On: Jul, 2020
- Category : Healthcare & Pharma
- Pages : 95
-
Biopharmaceuticals and vaccines are well recognized for their potential in treating incurable diseases for which conventional low-molecular-weight pharmaceuticals produced by chemical synthesis are ineffective and for preventing infectious diseases.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Biopharmaceutical and Vaccines market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Biopharmaceutical and Vaccines industry.
Based on our recent survey, we have several different scenarios about the Biopharmaceutical and Vaccines YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Biopharmaceutical and Vaccines will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Biopharmaceutical and Vaccines market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Biopharmaceutical and Vaccines market in terms of revenue.
Players, stakeholders, and other participants in the global Biopharmaceutical and Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Biopharmaceutical and Vaccines market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Biopharmaceutical and Vaccines market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Biopharmaceutical and Vaccines market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Biopharmaceutical and Vaccines market.
The following players are covered in this report:
Novartis
Pfizer
Sanofi
Roche
Abbott
Biogen Idec
Regeneron Pharmaceuticals
Alexion Pharmaceuticals
Johnson and Johnson
GlaxoSmithKline
Merck
Lonza
Boehringer Ingelheim
Rentschler
Biopharmaceutical and Vaccines Breakdown Data by Type
Biopharmaceutical
Vaccine Production
Biopharmaceutical and Vaccines Breakdown Data by Application
Pharmaceuticals Industry
Clinical Diagnosis
Scientific Research
Others
-
With tables and figures helping analyze worldwide Global Biopharmaceutical and Vaccines market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 Report Overview1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Biopharmaceutical and Vaccines Revenue
1.4 Market Analysis by Type
1.4.1 Global Biopharmaceutical and Vaccines Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Biopharmaceutical
1.4.3 Vaccine Production1.5 Market by Application
1.5.1 Global Biopharmaceutical and Vaccines Market Share by Application: 2020 VS 2026
1.5.2 Pharmaceuticals Industry
1.5.3 Clinical Diagnosis
1.5.4 Scientific Research
1.5.5 Others1.6 Coronavirus Disease 2019 (Covid-19): Biopharmaceutical and Vaccines Industry Impact
1.6.1 How the Covid-19 is Affecting the Biopharmaceutical and Vaccines Industry
1.6.1.1 Biopharmaceutical and Vaccines Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Biopharmaceutical and Vaccines Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Biopharmaceutical and Vaccines Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions2.1 Biopharmaceutical and Vaccines Market Perspective (2015-2026)
2.2 Biopharmaceutical and Vaccines Growth Trends by Regions
2.2.1 Biopharmaceutical and Vaccines Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Biopharmaceutical and Vaccines Historic Market Share by Regions (2015-2020)
2.2.3 Biopharmaceutical and Vaccines Forecasted Market Size by Regions (2021-2026)2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Biopharmaceutical and Vaccines Market Growth Strategy
2.3.6 Primary Interviews with Key Biopharmaceutical and Vaccines Players (Opinion Leaders)
3 Competition Landscape by Key Players3.1 Global Top Biopharmaceutical and Vaccines Players by Market Size
3.1.1 Global Top Biopharmaceutical and Vaccines Players by Revenue (2015-2020)
3.1.2 Global Biopharmaceutical and Vaccines Revenue Market Share by Players (2015-2020)
3.1.3 Global Biopharmaceutical and Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)3.2 Global Biopharmaceutical and Vaccines Market Concentration Ratio
3.2.1 Global Biopharmaceutical and Vaccines Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Biopharmaceutical and Vaccines Revenue in 20193.3 Biopharmaceutical and Vaccines Key Players Head office and Area Served
3.4 Key Players Biopharmaceutical and Vaccines Product Solution and Service
3.5 Date of Enter into Biopharmaceutical and Vaccines Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)4.1 Global Biopharmaceutical and Vaccines Historic Market Size by Type (2015-2020)
4.2 Global Biopharmaceutical and Vaccines Forecasted Market Size by Type (2021-2026)
5 Biopharmaceutical and Vaccines Breakdown Data by Application (2015-2026)5.1 Global Biopharmaceutical and Vaccines Market Size by Application (2015-2020)
5.2 Global Biopharmaceutical and Vaccines Forecasted Market Size by Application (2021-2026)
6 North America6.1 North America Biopharmaceutical and Vaccines Market Size (2015-2020)
6.2 Biopharmaceutical and Vaccines Key Players in North America (2019-2020)
6.3 North America Biopharmaceutical and Vaccines Market Size by Type (2015-2020)
6.4 North America Biopharmaceutical and Vaccines Market Size by Application (2015-2020)
7 Europe7.1 Europe Biopharmaceutical and Vaccines Market Size (2015-2020)
7.2 Biopharmaceutical and Vaccines Key Players in Europe (2019-2020)
7.3 Europe Biopharmaceutical and Vaccines Market Size by Type (2015-2020)
7.4 Europe Biopharmaceutical and Vaccines Market Size by Application (2015-2020)
8 China8.1 China Biopharmaceutical and Vaccines Market Size (2015-2020)
8.2 Biopharmaceutical and Vaccines Key Players in China (2019-2020)
8.3 China Biopharmaceutical and Vaccines Market Size by Type (2015-2020)
8.4 China Biopharmaceutical and Vaccines Market Size by Application (2015-2020)
9 Japan9.1 Japan Biopharmaceutical and Vaccines Market Size (2015-2020)
9.2 Biopharmaceutical and Vaccines Key Players in Japan (2019-2020)
9.3 Japan Biopharmaceutical and Vaccines Market Size by Type (2015-2020)
9.4 Japan Biopharmaceutical and Vaccines Market Size by Application (2015-2020)
10 Southeast Asia10.1 Southeast Asia Biopharmaceutical and Vaccines Market Size (2015-2020)
10.2 Biopharmaceutical and Vaccines Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Biopharmaceutical and Vaccines Market Size by Type (2015-2020)
10.4 Southeast Asia Biopharmaceutical and Vaccines Market Size by Application (2015-2020)
11 India11.1 India Biopharmaceutical and Vaccines Market Size (2015-2020)
11.2 Biopharmaceutical and Vaccines Key Players in India (2019-2020)
11.3 India Biopharmaceutical and Vaccines Market Size by Type (2015-2020)
11.4 India Biopharmaceutical and Vaccines Market Size by Application (2015-2020)
12 Central & South America12.1 Central & South America Biopharmaceutical and Vaccines Market Size (2015-2020)
12.2 Biopharmaceutical and Vaccines Key Players in Central & South America (2019-2020)
12.3 Central & South America Biopharmaceutical and Vaccines Market Size by Type (2015-2020)
12.4 Central & South America Biopharmaceutical and Vaccines Market Size by Application (2015-2020)
13 Key Players Profiles13.1 Novartis
13.1.1 Novartis Company Details
13.1.2 Novartis Business Overview and Its Total Revenue
13.1.3 Novartis Biopharmaceutical and Vaccines Introduction
13.1.4 Novartis Revenue in Biopharmaceutical and Vaccines Business (2015-2020))
13.1.5 Novartis Recent Development13.2 Pfizer
13.2.1 Pfizer Company Details
13.2.2 Pfizer Business Overview and Its Total Revenue
13.2.3 Pfizer Biopharmaceutical and Vaccines Introduction
13.2.4 Pfizer Revenue in Biopharmaceutical and Vaccines Business (2015-2020)
13.2.5 Pfizer Recent Development13.3 Sanofi
13.3.1 Sanofi Company Details
13.3.2 Sanofi Business Overview and Its Total Revenue
13.3.3 Sanofi Biopharmaceutical and Vaccines Introduction
13.3.4 Sanofi Revenue in Biopharmaceutical and Vaccines Business (2015-2020)
13.3.5 Sanofi Recent Development13.4 Roche
13.4.1 Roche Company Details
13.4.2 Roche Business Overview and Its Total Revenue
13.4.3 Roche Biopharmaceutical and Vaccines Introduction
13.4.4 Roche Revenue in Biopharmaceutical and Vaccines Business (2015-2020)
13.4.5 Roche Recent Development13.5 Abbott
13.5.1 Abbott Company Details
13.5.2 Abbott Business Overview and Its Total Revenue
13.5.3 Abbott Biopharmaceutical and Vaccines Introduction
13.5.4 Abbott Revenue in Biopharmaceutical and Vaccines Business (2015-2020)
13.5.5 Abbott Recent Development13.6 Biogen Idec
13.6.1 Biogen Idec Company Details
13.6.2 Biogen Idec Business Overview and Its Total Revenue
13.6.3 Biogen Idec Biopharmaceutical and Vaccines Introduction
13.6.4 Biogen Idec Revenue in Biopharmaceutical and Vaccines Business (2015-2020)
13.6.5 Biogen Idec Recent Development
13.7 Regeneron Pharmaceuticals
13.7.1 Regeneron Pharmaceuticals Company Details
13.7.2 Regeneron Pharmaceuticals Business Overview and Its Total Revenue
13.7.3 Regeneron Pharmaceuticals Biopharmaceutical and Vaccines Introduction
13.7.4 Regeneron Pharmaceuticals Revenue in Biopharmaceutical and Vaccines Business (2015-2020)
13.7.5 Regeneron Pharmaceuticals Recent Development
13.8 Alexion Pharmaceuticals
13.8.1 Alexion Pharmaceuticals Company Details
13.8.2 Alexion Pharmaceuticals Business Overview and Its Total Revenue
13.8.3 Alexion Pharmaceuticals Biopharmaceutical and Vaccines Introduction
13.8.4 Alexion Pharmaceuticals Revenue in Biopharmaceutical and Vaccines Business (2015-2020)
13.8.5 Alexion Pharmaceuticals Recent Development
13.9 Johnson and Johnson
13.9.1 Johnson and Johnson Company Details
13.9.2 Johnson and Johnson Business Overview and Its Total Revenue
13.9.3 Johnson and Johnson Biopharmaceutical and Vaccines Introduction
13.9.4 Johnson and Johnson Revenue in Biopharmaceutical and Vaccines Business (2015-2020)
13.9.5 Johnson and Johnson Recent Development13.10 GlaxoSmithKline
13.10.1 GlaxoSmithKline Company Details
13.10.2 GlaxoSmithKline Business Overview and Its Total Revenue
13.10.3 GlaxoSmithKline Biopharmaceutical and Vaccines Introduction
13.10.4 GlaxoSmithKline Revenue in Biopharmaceutical and Vaccines Business (2015-2020)
13.10.5 GlaxoSmithKline Recent Development
13.11 Merck
10.11.1 Merck Company Details
10.11.2 Merck Business Overview and Its Total Revenue
10.11.3 Merck Biopharmaceutical and Vaccines Introduction
10.11.4 Merck Revenue in Biopharmaceutical and Vaccines Business (2015-2020)
10.11.5 Merck Recent Development
13.12 Lonza
10.12.1 Lonza Company Details
10.12.2 Lonza Business Overview and Its Total Revenue
10.12.3 Lonza Biopharmaceutical and Vaccines Introduction
10.12.4 Lonza Revenue in Biopharmaceutical and Vaccines Business (2015-2020)
10.12.5 Lonza Recent Development
13.13 Boehringer Ingelheim
10.13.1 Boehringer Ingelheim Company Details
10.13.2 Boehringer Ingelheim Business Overview and Its Total Revenue
10.13.3 Boehringer Ingelheim Biopharmaceutical and Vaccines Introduction
10.13.4 Boehringer Ingelheim Revenue in Biopharmaceutical and Vaccines Business (2015-2020)
10.13.5 Boehringer Ingelheim Recent Development
13.14 Rentschler
10.14.1 Rentschler Company Details
10.14.2 Rentschler Business Overview and Its Total Revenue
10.14.3 Rentschler Biopharmaceutical and Vaccines Introduction
10.14.4 Rentschler Revenue in Biopharmaceutical and Vaccines Business (2015-2020)
10.14.5 Rentschler Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. Biopharmaceutical and Vaccines Key Market Segments
Table 2. Key Players Covered: Ranking by Biopharmaceutical and Vaccines Revenue
Table 3. Ranking of Global Top Biopharmaceutical and Vaccines Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Biopharmaceutical and Vaccines Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Biopharmaceutical
Table 6. Key Players of Vaccine Production
Table 7. COVID-19 Impact Global Market: (Four Biopharmaceutical and Vaccines Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Biopharmaceutical and Vaccines Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Biopharmaceutical and Vaccines Players to Combat Covid-19 Impact
Table 12. Global Biopharmaceutical and Vaccines Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Biopharmaceutical and Vaccines Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Biopharmaceutical and Vaccines Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Biopharmaceutical and Vaccines Market Share by Regions (2015-2020)
Table 16. Global Biopharmaceutical and Vaccines Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Biopharmaceutical and Vaccines Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Biopharmaceutical and Vaccines Market Growth Strategy
Table 22. Main Points Interviewed from Key Biopharmaceutical and Vaccines Players
Table 23. Global Biopharmaceutical and Vaccines Revenue by Players (2015-2020) (Million US$)
Table 24. Global Biopharmaceutical and Vaccines Market Share by Players (2015-2020)
Table 25. Global Top Biopharmaceutical and Vaccines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharmaceutical and Vaccines as of 2019)
Table 26. Global Biopharmaceutical and Vaccines by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Biopharmaceutical and Vaccines Product Solution and Service
Table 29. Date of Enter into Biopharmaceutical and Vaccines Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Biopharmaceutical and Vaccines Market Size by Type (2015-2020) (Million US$)
Table 32. Global Biopharmaceutical and Vaccines Market Size Share by Type (2015-2020)
Table 33. Global Biopharmaceutical and Vaccines Revenue Market Share by Type (2021-2026)
Table 34. Global Biopharmaceutical and Vaccines Market Size Share by Application (2015-2020)
Table 35. Global Biopharmaceutical and Vaccines Market Size by Application (2015-2020) (Million US$)
Table 36. Global Biopharmaceutical and Vaccines Market Size Share by Application (2021-2026)
Table 37. North America Key Players Biopharmaceutical and Vaccines Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Biopharmaceutical and Vaccines Market Share (2019-2020)
Table 39. North America Biopharmaceutical and Vaccines Market Size by Type (2015-2020) (Million US$)
Table 40. North America Biopharmaceutical and Vaccines Market Share by Type (2015-2020)
Table 41. North America Biopharmaceutical and Vaccines Market Size by Application (2015-2020) (Million US$)
Table 42. North America Biopharmaceutical and Vaccines Market Share by Application (2015-2020)
Table 43. Europe Key Players Biopharmaceutical and Vaccines Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Biopharmaceutical and Vaccines Market Share (2019-2020)
Table 45. Europe Biopharmaceutical and Vaccines Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Biopharmaceutical and Vaccines Market Share by Type (2015-2020)
Table 47. Europe Biopharmaceutical and Vaccines Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Biopharmaceutical and Vaccines Market Share by Application (2015-2020)
Table 49. China Key Players Biopharmaceutical and Vaccines Revenue (2019-2020) (Million US$)
Table 50. China Key Players Biopharmaceutical and Vaccines Market Share (2019-2020)
Table 51. China Biopharmaceutical and Vaccines Market Size by Type (2015-2020) (Million US$)
Table 52. China Biopharmaceutical and Vaccines Market Share by Type (2015-2020)
Table 53. China Biopharmaceutical and Vaccines Market Size by Application (2015-2020) (Million US$)
Table 54. China Biopharmaceutical and Vaccines Market Share by Application (2015-2020)
Table 55. Japan Key Players Biopharmaceutical and Vaccines Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Biopharmaceutical and Vaccines Market Share (2019-2020)
Table 57. Japan Biopharmaceutical and Vaccines Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Biopharmaceutical and Vaccines Market Share by Type (2015-2020)
Table 59. Japan Biopharmaceutical and Vaccines Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Biopharmaceutical and Vaccines Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Biopharmaceutical and Vaccines Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Biopharmaceutical and Vaccines Market Share (2019-2020)
Table 63. Southeast Asia Biopharmaceutical and Vaccines Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Biopharmaceutical and Vaccines Market Share by Type (2015-2020)
Table 65. Southeast Asia Biopharmaceutical and Vaccines Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Biopharmaceutical and Vaccines Market Share by Application (2015-2020)
Table 67. India Key Players Biopharmaceutical and Vaccines Revenue (2019-2020) (Million US$)
Table 68. India Key Players Biopharmaceutical and Vaccines Market Share (2019-2020)
Table 69. India Biopharmaceutical and Vaccines Market Size by Type (2015-2020) (Million US$)
Table 70. India Biopharmaceutical and Vaccines Market Share by Type (2015-2020)
Table 71. India Biopharmaceutical and Vaccines Market Size by Application (2015-2020) (Million US$)
Table 72. India Biopharmaceutical and Vaccines Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Biopharmaceutical and Vaccines Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Biopharmaceutical and Vaccines Market Share (2019-2020)
Table 75. Central & South America Biopharmaceutical and Vaccines Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Biopharmaceutical and Vaccines Market Share by Type (2015-2020)
Table 77. Central & South America Biopharmaceutical and Vaccines Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Biopharmaceutical and Vaccines Market Share by Application (2015-2020)
Table 79. Novartis Company Details
Table 80. Novartis Business Overview
Table 81. Novartis Product
Table 82. Novartis Revenue in Biopharmaceutical and Vaccines Business (2015-2020) (Million US$)
Table 83. Novartis Recent Development
Table 84. Pfizer Company Details
Table 85. Pfizer Business Overview
Table 86. Pfizer Product
Table 87. Pfizer Revenue in Biopharmaceutical and Vaccines Business (2015-2020) (Million US$)
Table 88. Pfizer Recent Development
Table 89. Sanofi Company Details
Table 90. Sanofi Business Overview
Table 91. Sanofi Product
Table 92. Sanofi Revenue in Biopharmaceutical and Vaccines Business (2015-2020) (Million US$)
Table 93. Sanofi Recent Development
Table 94. Roche Company Details
Table 95. Roche Business Overview
Table 96. Roche Product
Table 97. Roche Revenue in Biopharmaceutical and Vaccines Business (2015-2020) (Million US$)
Table 98. Roche Recent Development
Table 99. Abbott Company Details
Table 100. Abbott Business Overview
Table 101. Abbott Product
Table 102. Abbott Revenue in Biopharmaceutical and Vaccines Business (2015-2020) (Million US$)
Table 103. Abbott Recent Development
Table 104. Biogen Idec Company Details
Table 105. Biogen Idec Business Overview
Table 106. Biogen Idec Product
Table 107. Biogen Idec Revenue in Biopharmaceutical and Vaccines Business (2015-2020) (Million US$)
Table 108. Biogen Idec Recent Development
Table 109. Regeneron Pharmaceuticals Company Details
Table 110. Regeneron Pharmaceuticals Business Overview
Table 111. Regeneron Pharmaceuticals Product
Table 112. Regeneron Pharmaceuticals Revenue in Biopharmaceutical and Vaccines Business (2015-2020) (Million US$)
Table 113. Regeneron Pharmaceuticals Recent Development
Table 114. Alexion Pharmaceuticals Business Overview
Table 115. Alexion Pharmaceuticals Product
Table 116. Alexion Pharmaceuticals Company Details
Table 117. Alexion Pharmaceuticals Revenue in Biopharmaceutical and Vaccines Business (2015-2020) (Million US$)
Table 118. Alexion Pharmaceuticals Recent Development
Table 119. Johnson and Johnson Company Details
Table 120. Johnson and Johnson Business Overview
Table 121. Johnson and Johnson Product
Table 122. Johnson and Johnson Revenue in Biopharmaceutical and Vaccines Business (2015-2020) (Million US$)
Table 123. Johnson and Johnson Recent Development
Table 124. GlaxoSmithKline Company Details
Table 125. GlaxoSmithKline Business Overview
Table 126. GlaxoSmithKline Product
Table 127. GlaxoSmithKline Revenue in Biopharmaceutical and Vaccines Business (2015-2020) (Million US$)
Table 128. GlaxoSmithKline Recent Development
Table 129. Merck Company Details
Table 130. Merck Business Overview
Table 131. Merck Product
Table 132. Merck Revenue in Biopharmaceutical and Vaccines Business (2015-2020) (Million US$)
Table 133. Merck Recent Development
Table 134. Lonza Company Details
Table 135. Lonza Business Overview
Table 136. Lonza Product
Table 137. Lonza Revenue in Biopharmaceutical and Vaccines Business (2015-2020) (Million US$)
Table 138. Lonza Recent Development
Table 139. Boehringer Ingelheim Company Details
Table 140. Boehringer Ingelheim Business Overview
Table 141. Boehringer Ingelheim Product
Table 142. Boehringer Ingelheim Revenue in Biopharmaceutical and Vaccines Business (2015-2020) (Million US$)
Table 143. Boehringer Ingelheim Recent Development
Table 144. Rentschler Company Details
Table 145. Rentschler Business Overview
Table 146. Rentschler Product
Table 147. Rentschler Revenue in Biopharmaceutical and Vaccines Business (2015-2020) (Million US$)
Table 148. Rentschler Recent Development
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biopharmaceutical and Vaccines Market Share by Type: 2020 VS 2026
Figure 2. Biopharmaceutical Features
Figure 3. Vaccine Production Features
Figure 4. Global Biopharmaceutical and Vaccines Market Share by Application: 2020 VS 2026
Figure 5. Pharmaceuticals Industry Case Studies
Figure 6. Clinical Diagnosis Case Studies
Figure 7. Scientific Research Case Studies
Figure 8. Others Case Studies
Figure 9. Biopharmaceutical and Vaccines Report Years Considered
Figure 10. Global Biopharmaceutical and Vaccines Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Biopharmaceutical and Vaccines Market Share by Regions: 2020 VS 2026
Figure 12. Global Biopharmaceutical and Vaccines Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Biopharmaceutical and Vaccines Market Share by Players in 2019
Figure 15. Global Top Biopharmaceutical and Vaccines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharmaceutical and Vaccines as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Biopharmaceutical and Vaccines Revenue in 2019
Figure 17. North America Biopharmaceutical and Vaccines Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Biopharmaceutical and Vaccines Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Biopharmaceutical and Vaccines Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Biopharmaceutical and Vaccines Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Biopharmaceutical and Vaccines Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Biopharmaceutical and Vaccines Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Biopharmaceutical and Vaccines Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Novartis Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2015-2020)
Figure 26. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Pfizer Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2015-2020)
Figure 28. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Sanofi Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2015-2020)
Figure 30. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Roche Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2015-2020)
Figure 32. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Abbott Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2015-2020)
Figure 34. Biogen Idec Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Biogen Idec Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2015-2020)
Figure 36. Regeneron Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Regeneron Pharmaceuticals Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2015-2020)
Figure 38. Alexion Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Alexion Pharmaceuticals Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2015-2020)
Figure 40. Johnson and Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Johnson and Johnson Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2015-2020)
Figure 42. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. GlaxoSmithKline Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2015-2020)
Figure 44. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Merck Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2015-2020)
Figure 46. Lonza Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Lonza Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2015-2020)
Figure 48. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Boehringer Ingelheim Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2015-2020)
Figure 50. Rentschler Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Rentschler Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2015-2020)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
-
The Global Biopharmaceutical and Vaccines Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
Global Biopharmaceutical and Vaccines has a wide range of applications, including
It is expected that the Global Biopharmaceutical and Vaccines Market will reach USD XX million by 2029.
Yes, the add-on segmentation is available in the premium customised version of the Global Biopharmaceutical and Vaccines Market report for a more in-depth analysis. It aids in the calculation of refined and precise market values.
Companies in the Global Biopharmaceutical and Vaccines Industry are thoroughly researched and profiled in order to determine why certain trends will have a significant impact and how they will be factored into the Global Biopharmaceutical and Vaccines Market's trajectory and future outlook.
